Anteris Technologies Global Corp. (ASX:AVR)

Market Cap	945.82M +261.4%
Revenue (ttm)	3.24M -9.6%
Net Income	-149.70M
EPS	-2.34
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,592
Open	9.55
Previous Close	9.55
Day's Range	9.41 - 9.88
52-Week Range	5.20 - 15.47
Beta	0.73
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About ASX:AVR

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tiss...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 174
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AVR

Financial Performance

In 2025, ASX:AVR's revenue was $1.91 million, a decrease of -29.23% compared to the previous year's $2.70 million. Losses were -$94.14 million, 23.4% more than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 12, 2026

Data Sources Report a data error